Pharmacist Portal Dispense an ePrescription
Orexigen Therapeutics has set out to recruit the 10,000 participants that it requires for the cardiovascular risk study of Contrave, its lead weight loss drug candidate...
A further update on the situation with Orlistat; we have spoken to one of the manufacturers (Teva) and they have assured us that they will be able to supply us in mid-July...
It is an observed phenomenon that people tend to put on weight when they get old...
Vivus Inc, the pharmaceutical company responsible for Qnexa, has announced that the Food and Drug Administration’s (FDA) decision on their weight loss drug is pending and to be released on July 17th...
One of the scientists responsible for the invention of Viagra has done it once again and has created a revolutionary treatment for those who suffer from premature ejaculation (PE)...